Breakthrough Chemistry, Inc.
BKTH
$0.16
-$0.02-11.11%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | 2.22% | 2.22% | 7,600.00% | -54.17% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 2.22% | 2.22% | 7,600.00% | -54.17% | |
| Cost of Revenue | 0.00% | 0.00% | 288.68% | -84.00% | |
| Gross Profit | 8.33% | 8.33% | -141.82% | 137.04% | |
| SG&A Expenses | 42.16% | 42.16% | 27.66% | 267.82% | |
| Depreciation & Amortization | 0.00% | 0.00% | 9.80% | 79.37% | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 17.81% | 17.81% | 42.49% | 100.44% | |
| Operating Income | -20.79% | -20.79% | -32.56% | -142.37% | |
| Income Before Tax | -2.28% | -2.28% | -13.16% | -68.92% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -2.28% | -2.28% | -13.16% | -68.92% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -2.28% | -2.28% | -13.16% | -68.92% | |
| EBIT | -20.79% | -20.79% | -32.56% | -142.37% | |
| EBITDA | -48.31% | -48.31% | -36.17% | -151.59% | |
| EPS Basic | 5.88% | 5.88% | -4.67% | -54.55% | |
| Normalized Basic EPS | 4.76% | 4.76% | -4.48% | -52.38% | |
| EPS Diluted | 5.88% | 5.88% | -4.67% | -54.55% | |
| Normalized Diluted EPS | 4.76% | 4.76% | -4.48% | -52.38% | |
| Average Basic Shares Outstanding | 6.96% | 6.96% | 8.24% | 8.15% | |
| Average Diluted Shares Outstanding | 6.96% | 6.96% | 8.24% | 8.15% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |